Literature DB >> 24175236

Cytoprotection behind heme oxygenase-1 in renal diseases.

Matheus Correa-Costa1, Mariane Tami Amano, Niels Olsen Saraiva Câmara.   

Abstract

Renal insults are considered a public health problem and are linked to increased rates of morbidity and mortality worldwide. The heme oxygenase (HO) system consists of evolutionary specialized machinery that degrades free heme and produces carbon monoxide, biliverdin and free iron. In this sense, the inducible isoform HO-1 seems to develop an important role and is widely studied. The reaction involved with the HO-1 molecule provides protection to injured tissue, directly by reducing the toxic heme molecule and indirectly by the release of its byproducts. The up regulation of HO-1 enzyme has largely been described as providing antioxidant, antiapoptotic, anti-inflammatory and immunomodulatory properties. Several works have explored the importance of HO-1 in renal diseases and they have provided consistent evidence that its overexpression has beneficial effects in such injuries. So, in this review we will focus on the role of HO-1 in kidney insults, exploring the protective effects of its up regulation and the enhanced deleterious effects of its inhibition or gene deletion.

Entities:  

Keywords:  Anti-inflammatory; Antioxidants; Heme oxigenase-1; Renal cytoprotection; Renal diseases

Year:  2012        PMID: 24175236      PMCID: PMC3782207          DOI: 10.5527/wjn.v1.i1.4

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  84 in total

Review 1.  Inflammation in acute kidney injury.

Authors:  Gilbert R Kinsey; Li Li; Mark D Okusa
Journal:  Nephron Exp Nephrol       Date:  2008-09-18

2.  Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.

Authors:  Eric L R Bédard; Jifu Jiang; Neil Parry; Hao Wang; Weihua Liu; Bertha Garcia; Peter Kim; Subrata Chakrabarti; Roland Buelow; Robert Zhong
Journal:  Transpl Int       Date:  2005-03       Impact factor: 3.782

3.  Change in renal heme oxygenase expression in cyclosporine A-induced injury.

Authors:  Rita Rezzani; Luigi Rodella; Barbara Buffoli; Alvin A Goodman; Nader G Abraham; Elias A Lianos; Rossella Bianchi
Journal:  J Histochem Cytochem       Date:  2005-01       Impact factor: 2.479

4.  Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation.

Authors:  Hang Li; Lianshan Zhang; Fuxu Wang; Yonghong Shi; Yunzhuo Ren; Qingjuan Liu; Yanping Cao; Huijun Duan
Journal:  Am J Nephrol       Date:  2011-03-08       Impact factor: 3.754

Review 5.  Heme oxygenase and the kidney.

Authors:  Nathalie Hill-Kapturczak; Se-Ho Chang; Anupam Agarwal
Journal:  DNA Cell Biol       Date:  2002-04       Impact factor: 3.311

6.  The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury.

Authors:  G M Gonçalves; M A Cenedeze; C Q Feitoza; P M H Wang; A P F Bertocchi; M J Damião; H S Pinheiro; V P Antunes Teixeira; M A dos Reis; A Pacheco-Silva; N O S Câmara
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

7.  The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.

Authors:  Joseph Fomusi Ndisang; Ashok Jadhav
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-28       Impact factor: 3.619

8.  Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.

Authors:  Jeong-Hae Kie; Matthias H Kapturczak; Amie Traylor; Anupam Agarwal; Nathalie Hill-Kapturczak
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

9.  Differential expressions of heme oxygenase-1 gene in CD25- and CD25+ subsets of human CD4+ T cells.

Authors:  Hyun-Ock Pae; Gi-Su Oh; Byung-Min Choi; Soo-Cheon Chae; Hun-Taeg Chung
Journal:  Biochem Biophys Res Commun       Date:  2003-07-04       Impact factor: 3.575

Review 10.  Heme oxygenase and renal disease.

Authors:  Tambi Jarmi; Anupam Agarwal
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

View more
  6 in total

1.  Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury.

Authors:  Subhashini Bolisetty; Amie Traylor; Reny Joseph; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16

Review 2.  Application of carbon monoxide for treatment of acute kidney injury.

Authors:  Atsunori Nakao; Taihei Yamada; Keisuke Kohama; Norichika Yoshie; Noritomo Fujisaki; Joji Kotani
Journal:  Acute Med Surg       Date:  2014-04-23

3.  Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1.

Authors:  Mariana Yasue Saito Miyagi; Marilia Seelaender; Angela Castoldi; Danilo Candido de Almeida; Aline Villa Nova Bacurau; Vinicius Andrade-Oliveira; Lucas Maceratesi Enjiu; Marcus Pisciottano; Caroline Yuri Hayashida; Meire Ioshie Hiyane; Patricia Chakur Brum; Niels Olsen Saraiva Camara; Mariane Tami Amano
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

4.  Ethyl Pyruvate Directly Attenuates Active Secretion of HMGB1 in Proximal Tubular Cells via Induction of Heme Oxygenase-1.

Authors:  Min Suk Seo; Hye Jung Kim; Hwajin Kim; Sang Won Park
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

5.  The molecular fingerprint of lung inflammation after blunt chest trauma.

Authors:  Christian Ehrnthaller; Michael Flierl; Mario Perl; Stephanie Denk; Heike Unnewehr; Peter A Ward; Peter Radermacher; Anita Ignatius; Florian Gebhard; Arul Chinnaiyan; Markus Huber-Lang
Journal:  Eur J Med Res       Date:  2015-08-25       Impact factor: 2.175

Review 6.  Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?

Authors:  Daniela Corona; Burcin Ekser; Rossella Gioco; Massimo Caruso; Chiara Schipa; Pierfrancesco Veroux; Alessia Giaquinta; Antonio Granata; Massimiliano Veroux
Journal:  Biomolecules       Date:  2020-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.